Profile data is unavailable for this security.
About the company
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its pipeline also includes breast and other cancers. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, Ga-DOTA-RM2, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol.
- Revenue in USD (TTM)1.50bn
- Net income in USD427.61m
- Incorporated2007
- Employees834.00
- LocationLantheus Holdings Inc331 Treble Cove RdNORTH BILLERICA 01862United StatesUSA
- Phone+1 (978) 671-8001
- Fax+1 (302) 636-5454
- Websitehttps://www.lantheus.com/
More ▼
Mergers & acquisitions
| Acquired company | LNTH:NMQ since announced | Transaction value |
|---|---|---|
| Meilleur Technologies Inc | -31.01% | -- |
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Envista Holdings Corp | 2.50bn | -1.34bn | 3.53bn | 12.80k | -- | 1.15 | -- | 1.41 | -7.77 | -7.77 | 14.51 | 17.86 | 0.4106 | 4.21 | 6.19 | 195,570.30 | -21.93 | 1.94 | -25.27 | 2.34 | 54.20 | 57.65 | -53.42 | 5.29 | 1.77 | 3.13 | 0.3163 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
| DENTSPLY SIRONA Inc | 3.90bn | -413.00m | 3.60bn | 15.00k | -- | 1.42 | -- | 0.9237 | -2.07 | -2.07 | 18.91 | 12.53 | 0.5641 | 2.94 | 5.91 | 260,000.00 | -5.93 | -1.14 | -7.41 | -1.32 | 52.18 | 53.65 | -10.51 | -2.51 | 0.8444 | 3.21 | 0.471 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Axonics Inc | 431.90m | -5.66m | 3.60bn | 797.00 | -- | 5.42 | 528.11 | 8.34 | -0.108 | -0.108 | 8.52 | 13.00 | 0.602 | 1.07 | 7.74 | 541,909.70 | -0.7889 | -12.67 | -0.848 | -13.76 | 76.59 | 70.04 | -1.31 | -29.68 | 6.40 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
| Guardant Health Inc | 692.26m | -512.41m | 3.67bn | 1.78k | -- | -- | -- | 5.31 | -4.24 | -4.24 | 5.70 | -0.488 | 0.415 | 3.68 | 7.81 | 389,126.50 | -30.72 | -22.26 | -35.19 | -24.59 | 60.31 | 64.62 | -74.02 | -97.07 | 5.85 | -8.04 | 1.06 | -- | 25.45 | 44.14 | 26.76 | -- | 0.2786 | -- |
| ICU Medical Inc | 2.30bn | -70.79m | 4.35bn | 14.00k | -- | 2.13 | 27.72 | 1.89 | -2.92 | -2.92 | 94.90 | 83.43 | 0.5267 | 2.13 | 14.68 | 164,591.20 | -1.62 | 1.46 | -1.83 | 1.65 | 32.47 | 34.11 | -3.07 | 2.23 | 1.08 | 0.5555 | 0.4412 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
| Integer Holdings Corp | 1.68bn | 114.44m | 4.59bn | 10.50k | 42.21 | 2.83 | 20.75 | 2.73 | 3.24 | 3.22 | 47.87 | 48.33 | 0.5594 | 4.93 | 5.14 | 160,023.80 | 3.81 | 3.28 | 4.10 | 3.53 | 27.06 | 26.94 | 6.81 | 6.40 | 2.09 | 4.11 | 0.4028 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Haemonetics Corporation | 1.36bn | 123.81m | 4.78bn | 3.66k | 38.78 | 5.35 | 20.48 | 3.51 | 2.41 | 2.41 | 26.48 | 17.44 | 0.6001 | 1.87 | 7.02 | 372,224.00 | 5.46 | 5.02 | 6.19 | 6.07 | 54.02 | 51.74 | 9.10 | 8.11 | 2.09 | 27.43 | 0.5823 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| Procept Biorobotics Corp | 199.84m | -100.06m | 5.17bn | 626.00 | -- | 20.57 | -- | 25.85 | -1.95 | -1.95 | 3.89 | 4.64 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
| Inspire Medical Systems Inc | 755.59m | 33.05m | 5.72bn | 1.01k | 175.30 | 8.21 | 150.41 | 7.57 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Lantheus Holdings Inc | 1.50bn | 427.61m | 5.92bn | 834.00 | 14.15 | 5.02 | 12.08 | 3.96 | 6.02 | 6.02 | 21.09 | 16.97 | 0.8383 | 8.28 | 5.09 | 1,794,723.00 | 23.95 | 6.69 | 32.76 | 7.73 | 64.78 | 57.56 | 28.57 | 9.02 | 1.56 | -- | 0.324 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Merit Medical Systems Inc | 1.33bn | 120.04m | 6.08bn | 6.95k | 51.06 | 4.59 | 27.90 | 4.58 | 2.04 | 2.04 | 22.55 | 22.71 | 0.6334 | 2.29 | 7.41 | 190,772.80 | 5.73 | 2.45 | 6.32 | 2.77 | 46.83 | 44.50 | 9.05 | 3.91 | 3.82 | 31.88 | 0.3619 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| Stevanato Group SpA | 1.16bn | 121.84m | 6.28bn | 5.64k | 45.73 | 4.03 | 30.63 | 5.41 | 0.4537 | 0.4537 | 4.32 | 5.15 | 0.5284 | 2.75 | 2.66 | 206,254.60 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Glaukos Corp | 360.35m | -149.57m | 7.92bn | 907.00 | -- | 11.84 | -- | 21.98 | -2.96 | -2.96 | 7.06 | 12.13 | 0.3843 | 1.69 | 7.53 | 397,295.50 | -15.95 | -8.73 | -17.23 | -9.35 | 76.61 | 74.77 | -41.51 | -28.69 | 4.71 | -311.24 | 0.1591 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Repligen Corp | 622.64m | -17.13m | 8.32bn | 1.78k | -- | -- | 242.55 | 13.37 | -0.3079 | -0.3079 | 11.09 | -- | -- | -- | -- | 349,206.40 | -- | 4.38 | -- | 5.03 | 49.96 | 55.43 | -2.75 | 15.91 | -- | -- | -- | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Henry Schein, Inc. | 12.50bn | 314.00m | 8.41bn | 25.00k | 27.62 | 2.41 | 14.21 | 0.6729 | 2.44 | 2.44 | 96.89 | 27.99 | 1.22 | 4.77 | 7.73 | 499,960.00 | 2.97 | 6.09 | 4.86 | 10.44 | 31.59 | 30.04 | 2.42 | 4.40 | 0.817 | 6.23 | 0.348 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
Data as of Nov 12 2024. Currency figures normalised to Lantheus Holdings Inc's reporting currency: US Dollar USD
43.45%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 7.59m | 10.93% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 7.36m | 10.61% |
| Janus Henderson Investors US LLCas of 30 Jun 2024 | 3.28m | 4.72% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 2.49m | 3.59% |
| Farallon Capital Management LLCas of 30 Jun 2024 | 2.28m | 3.28% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.65m | 2.38% |
| Westfield Capital Management Co. LPas of 30 Jun 2024 | 1.64m | 2.36% |
| Macquarie Investment Management Business Trustas of 30 Jun 2024 | 1.38m | 1.98% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.25m | 1.80% |
| Reinhart Partners, Inc.as of 30 Sep 2024 | 1.24m | 1.79% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
